Shanghai MicroPort MedBot (Group) Co., Ltd. (2252)’in fiyatı nedir?

Shanghai MicroPort MedBot (Group) Co., Ltd. (2252)’in fiyatı $2.91’dir

Shanghai MicroPort MedBot (Group) Co., Ltd. (2252)’in piyasa değeri nedir?

Shanghai MicroPort MedBot (Group) Co., Ltd. (2252)’in piyasa değeri $2.98B’dir.

Shanghai MicroPort MedBot (Group) Co., Ltd. (2252) Kazanç

Shanghai MicroPort MedBot (Group) Co., Ltd. focuses on the comprehensive research, development, design, production, and distribution of surgical robotic systems, catering to markets in China and Europe. Their innovative product range features Toumai, a versatile laparoscopic surgical robot employed in urologic, gynecologic, thoracic, and general surgeries. They also provide DFVision, a 3D electronic laparoscope designed to improve visualization during abdominal, thoracic, and pelvic operations. For orthopedic procedures, the Honghu robot aids in knee and hip joint replacements, while the R-One system is specifically engineered for vascular interventions like coronary angioplasty. The iSR'obot, known as the Mona Lisa robotic system, specializes in transperineal prostate biopsies. Additionally, the company's offerings extend to specialized robots for spinal procedures, trans-bronchial diagnosis and treatment, TAVR (Transcatheter Aortic Valve Replacement), and automated needle-targeting systems for precise percutaneous lung biopsies and nephrolithotomy. Founded in 2014 and headquartered in Shanghai, China, the company functions as a subsidiary of MicroPort Scientific Corporation.

Yıl	Kazanç	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Kazanç

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	Kazanç	Kazanç Farkı	Ülke
Abbott Laboratories ABT.US	$7.51B	-	US
Stryker Corporation SYK.US	$5.15B	-	US
Medtronic plc MDT.US	$5.56B	-	IE
Boston Scientific Corporation BSX.US	$3.86B	-	US
Edwards Lifesciences Corporation EW.US	$1.42B	-	US

Şirket

Kazanç

Kazanç Farkı

Ülke